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CASE REPORT
INTRODUCTION
Papilla Vater’s tumors are benign or malignant 
tumors in the ampulla of Vater and periampullary 
region. These represent 1.5% of gastrointestinal 
(GI) tract tumors with incidence about 6 million/
year.1 Tumors of the papilla Vater are very rare; 
the majority of tumors of the minor papilla of the 
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ABSTRACT
Tumors of the papilla Vater are very rare. Papilla Vater’s tumors are benign or malignant tumors in 
the ampulla of Vater and periampullary region. Blockage of ampulla leads to the development of obstructive 
jaundice; intermittent cholangitis, epigastric discomfort and weight loss. Treatment possibilities include 
endoscopic ampulectomy, surgical transduodenal excision of tumors of the ampulla and pancreatoduodenectomy 
(PDE). Prognosis depends on histological typing of the tumor and their clinical stage. We report a case of papilla 
Vater’s tumor in elderly with comorbidities based on literature review. 
A 68-year-old female patient was referred for evaluation of intra and extra hepatic bile duct dilatation noted 
on abdominal ultrasonography. She complained of intermittent epigastric and right upper abdominal pain, with 
yellowish skin for two months. The laboratory findings showed leukocytosis, hyperbilirubinemia, abnormal liver 
function test, and high Ca 19-9. An endoscopic retrograde cholangiopancreatography (ERCP) revealed a distal 
obstruction caused by papilla Vater’s tumor. Abdominal computed tomography (CT) with contrast, revealed 
a dilated common bile duct and pancreatic duct. The histologic evaluation was highly suggestive for dysplasia. 
She is now on a schedule for a Whipple procedure. 
To make a true diagnosis and optimal treatment of papilla Vater’s tumor is multimodal. By doing 
a comprehensive geriatric assessment, with a careful modality selection, a Whipple procedure can be performed 
in elderly (65 years) safely. The post operative morbidity and mortality depends on their multi morbidity. Surgical, 
endoscopic, or radiologic biliary decompression; relief of gastric outlet obstruction; and adequate pain control 
may improve the quality of life but do not affect overall survival rate. By building a great interdisciplinary 
teamwork, the quality of life increased as follows. 
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duodenum are neuroendocrine tumors (NETs), such 
as somatostatinomas and carcinoid tumors. Carcinoid 
tumors arise from enterochromaffin cells, and 
gastrointestinal carcinoids are usually located in the 
appendix, ileum, stomach, and rectum; only 8 cases 
have been reported in the literature.2 
Blockage of ampulla leads to the development 
of obstructive jaundice; intermittent cholangitis, 
epigastric discomfort and weight loss. Frequently 
the patient underwent an endoscopy, endosonography, 
contrast enhanced computed tomography (CT) and 
endoscopic retrograde cholangiopancreatography 
(ERCP).2  
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Treatment possibilities include endoscopic 
ampulectomy, surgical transduodenal excision of 
tumors of the ampulla and pancreatoduodenectomy 
(PDE). Tumors arising from the papilla of Vater have 
a better prognosis than carcinomas of the pancreas and 
bile duct, and it has quite a different pathological nature 
from these tumors.3 Prognosis depends on histological 
typing of the tumor and their clinical stage and maybe 
associated with an excellent prognosis, and if the 
tumor is limited to the duodenal mucosa without any 
invasion into the adjacent pancreas then the five-year 
survival may be as high as 90%. Prognosis for patients 
with carcinoma of papilla Vater is better than other 
periampullary tumors. The overall survival after the 
Whipple operation for pancreatic adenocarcinoma is 
about 20 percent at five years after surgery. Patients 
without spread of cancer into their lymph nodes may 
have up to 40% survival.1-3 
CASE ILLUSTRATION
A 68-year-old female was referred to our department 
for evaluation of dilatation of the main pancreatic duct, 
intra and extra hepatic biliary duct, with a double 
duct sign, noted on abdominal ultrasonography (US). 
She complained of intermittent right upper quadrant 
and epigastric pain 2 months prior to admissions, 
followed by yellowish skin, and dark brown colored 
urine. She also complained about nausea, vomiting 
and low dietary intake during 2 weeks prior to referral. 
The patient had a history of hepatic abscess. She did not 
drink alcohol or smoking or any particular medications 
and denied sweating and diarrhea. Laboratory data on 
admission were as follows: total bilirubin 31.6 mg/
dL, aspartate aminotransferase (AST) 97 U/L, alanine 
transaminase (ALT) 39 U/L, alkaline phosphatase 
(ALP) 1,014 U/L, and gamma glutamyl transpeptidase 
(GGT) 806 U/L. The complete blood count showed 
leukocytosis 12,100/mm3, neutrophil segment 85, 
and hypoalbuminemia 2.5 mg/dL. Serum electrolytes 
were within normal limits. On the fourth days of 
hospitalization, the patient underwent ERCP that 
showed a distal obstruction of the biliary duct. The CA 
19-9 was 8,378 U/mL. On the CT scan, the pancreatic 
duct was diffusely dilated without a definite mass and 
the common bile duct was dilated. 
The abdominal US revealed a dilatation at intra and 
extra hepatic biliary and common bile duct (CBD); 
sludge in gall bladder. There was no sign of pancreatic 
duct enlargement. The summary from this examination 
was enlargement of intra and extra hepatic biliary duct 
and CBD (figure 1). On the CT scan, the pancreatic 
duct was diffusely dilated without a definite mass 
and the common bile duct was slightly dilated, with 
a non specific hepatomegaly, and no sign of lymph 
nodes enlargement. Endoscopy showed papilla Vater’s 
prominent with a tumor, cholangiogram showed an 
enlargement of CBD, intra and extra hepatic duct. From 
pancreatogram, the main pancreatic duct (MPD) was 
nonvisualized. The conclusion for this ERCP was, there 
is a distal obstruction of CBD at causa papilla Vater’s 
tumor (figure 2). Multiple deep biopsies taken from this 
nodule during ERCP. The pathologic findings revealed 
highly suggestive dysplasia duodenum mucosal. Under 
the diagnosis of a tumor of the papilla Vater, the patient 
underwent double pigtail 10 Fr stenting procedure at 
the CBD (figure 3).
Figure 1. Abdominal ultrasonography showed enlargement of intra 
hepatic, extra hepatic and common bile duct
Figure 2. ERCP showed distal obstruction of CBD at causa papilla 
Vater’s tumor
Figure 3. ERCP showed double pigtails stenting 10 Fr at common 
bile duct
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DISCUSSION
A classical carcinoid tumor is usually still referred to 
as a carcinoid tumor. The incidence of gastrointestinal 
carcinoids is 1.6-2.0 cases per 100,000 persons/
year, but the prevalence maybe higher.2 Qiao et 
al reported ampullary carcinomas accounting for 
approximately 0.2% of all tumors in GI tract types can 
be found in this area originating from the duodenal 
mucosa or from the bile duct or the pancreatic duct.3 
The etiology of the disease is poorly understood. 
Patients with familial adenomatous polyposis (FAP) 
have an increased risk of both benign and malignant 
papilla Vater’s tumor. Most of these tumors are 
resectable for cure at diagnosis; however, the 5-years 
survival rate is only approximately 40-67% at best. 
Operative mortality rates have decreased significantly 
over the last decade because of increased surgical 
experience, improved anesthesia, better preoperative 
imaging and interdisciplinary pre and post operative 
management. Post operative mortality rates in our 
hospital are 20% and at the best centers are 1-2%. 
A higher rate of ampullary tumor is observed in male. 
Ampullary tumor or cancer most often seen in the fifth 
through the seventh decades of life.4 In this case, our 
patient is a 68 years old female.
The tumor or carcinoma of the ampulla of Vater 
is part of the spectrum of periampullary carcinomas, 
usually present with jaundice, and abdominal pain.1,2 
Jaundice is the presenting symptom in 73% of 
resected patients and in 80% of unresected patients 
in the 28-year experience published by Talamini 
et al.4 Jaundice may intermittently wax and wane 
because of central necrosis and sloughing or pressure 
opening of an obstructed duct. Other clinical features 
include progressive weight loss in 61% cases, as seen 
in this case. Abdominal pain and back pain were 
present in 46% and it is usually dull, aching mid 
epigastric pain or right hypochondric pain, and back 
pain may be a sign of advanced stage. In this case, 
there is an abdominal pain and radiating back pain. 
At the third day of hospitalization, the patient was taking 
a nonsteroidal anti-inflammatory drugs to relieve 
the pain. There is a significant progress from the visual 
analog score, from 7 to 1. Pruritus associated with 
jaundice in 13-38% cases. Dyspepsia and vomiting 
may be present if compromise of the duodenal lumen 
leads to gastric outlet obstructions, and can contribute 
to loss of appetite. In this case, there is a dyspepsia and 
loss of appetite.4 At the first day of hospitalizations, 
with good collaborations with nutritionist, we give 
blenderized diet through nasogastric tube. Proton pump 
inhibitors and pro kinetic drugs were also be given to 
the patient. As we know there is an interaction between 
pain and dyspepsia, because of the pro inflammatory 
reactions that enhance tumor necrosis factor alpha 
(TNF-alpha) due to local infections. Treatment for pain 
and dyspepsia has to commence at once. 
From the laboratory studies, blood biochemistry, 
test for anemia caused by occult bleeding from 
the ampullary mass. Hyperbilirubinemia conjugated 
type, rise in serum ALT, AST, and alkaline phosphatase 
level due to blockage of the biliary outflow and biliary 
obstructions. As seen in this patient, we found there 
is a slight anemia, hyperbilirubinemia, rise in AST 
and ALT. Currently, no tumor marker is sensitive or 
specific enough to serve as a reliable screening tools 
for this case. Carbohydrate antigen (CA) 19-9 is 
the most studied and sensit ive marker for 
pancreatobiliary neoplasms at present. In this case 
the CA 19-9 is 8,378 U/mL. 
Abdominal US is the most useful noninvasive initial 
investigations for distinguishing medical from surgical 
causes of jaundice and we can identify dilated ducts, 
liver metastasis (in almost 90% cases), ascites and nodal 
metastasis. The level of obstruction can be assessed in 
90% patient, as seen in this case. The limitation of 
abdominal ultrasound is the effectiveness related to the 
skill of the user, very superficial lesions and very deep 
lesions may be missed. Distinguishing a metastasis 
from a hemangioma may be difficult, sensitivity is 
80-90%, and information is inferior to that obtained 
by CT scan or magnetic resonance imaging (MRI). 
Poor bowel preparation may obscure the important 
pathology. It has been found to be a diagnostic tools 
of ampulla of Vater carcinoma only in 23.8% cases. 
In this case, the cause of distal obstruction at CBD 
are not seen in this modalities. CT is a noninvasive 
procedure. CT scan is superior to US but inferior to 
endoscopic ultrasound (EUS) for tumor or carcinoma 
of the ampulla of Vater unless extensive tumor is 
present. CT scan is better in evaluating resectability 
and preoperative staging. It gives better assessment of 
invasion, encasement, or compression of vessels and 
adjacent organs. CT-guided biopsy may be obtained 
when mass lesions are present, but endoscopic biopsy 
is preferred. In this case, CT revealed an enlargement 
of CBD and no sign of mass or space occupying lesions 
in pancreas, metastasis and lymph nodes enlargement. 
ERCP allows diagnostic and therapeutic access 
to both the common bile duct and pancreatic duct. 
The procedure displays the details of ductal anatomy 
and accurately demonstrates the level and nature of 
the obstruction. Anatomical variations in ducts can 
be evaluated carefully4. In this case, the side viewing 
endoscopy revealed the papila Vater’s tumor that 
cause the obstruction of distal CBD. ERCP allows 
therapeutic procedures, such as sphincterotomy, 
stenting, and nasobiliary drainage. In this case, stent 
double pigtails was placed and it reveals a good 
progression for hyperbilirubinemia. Endoscopic 
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excision of small periampullary tumors is gaining in 
popularity. It permits sampling of pancreatic juice, bile, 
and brush/grasp biopsy. The ERCP disadvantage is an 
invasive procedure that requires an expert endoscopist 
or radiologist and a cooperative patient. Very small 
tumors (< 1 cm) can be missed. ERCP is not possible 
if access to the duodenal papilla is difficult to obtain 
because of diverticula, anatomical ductal variations, 
or prior surgical bypass.4 
The surveillance epidemiology and end result 
(SEER) database indicates adenocarcinoma is 
the most frequently identified histology for papilla 
Vater’s cancer. Adenocarcinoma not otherwise specific 
(NOS) was reported in 65% of cases. Carcinoma 
NOS was reported in 8.1%; adenocarcinoma arising 
from adenoma (adenocarcinoma in villous adenoma, 
in tubulovillous adenoma, in adenomatous polyp and 
villous adenocarcinoma) was third most common, 
reported  in 7.5%. Other pathologic diagnosis reported 
included papillary adenocarcinoma (5.6%), mucinous 
adenocarcinoma (4.7%), and signet ring cell carcinoma 
(2%). In this case the specimen from papilla Vater’s 
tumor was taken during ERCP. The conclusion from 
histologic finding is high grade dysplasia of duodenum 
mucosa.4 
Surgical resection of an ampullary carcinoma 
is the primary modality of treatment. The highest 
cure rates are achieved if the tumor is localized to 
the ampullary region and complete resection is 
achieved. Diagnostic staging laparoscopy may be 
indicated to avoid laparotomy in the setting of advanced 
disease with distant occult metastasis. PDE Whipple 
is the standard procedure. Pylorus preserving PDE or 
classic Whipple can be performed depending on extent 
of tumor and surgeon preference. With improvement 
in interdisciplinary postoperative management and 
surgical technique, operative mortality rates are as 
low as 1% in experienced centers.5 Resectability 
rates for ampullary carcinoma was up to 96% in 
the 1990s.6 Local resection (ampullectomy) may be 
considered for patients with an ampullary adenoma 
with absence of dysplasia on preoperative biopsies 
who are inappropriate candidates for PDE. Recurrence 
rate is high in this population; therefore, surveillance 
endoscopy is indicated. Extensive preoperative 
assessment of cardiac, respiratory, renal, and cerebral 
functions should be performed in older patients or 
those with comorbid conditions. Toh et al reported 25 
patients (13 male, 12 female) with a median age of 65 
years who had an ampullary tumor. The resectability 
rate was 88%, with no operative mortality. The 5-years 
survival rate of patients who underwent radical 
resection was 49%. They concluded that local resection 
is recommended only for small, benign tumors and 
for patients who may be unfit for radical surgery; 
otherwise, pylorus-preserving PDE is safe and the most 
effective procedure.7
Interdisciplinary management including: (1) 
Assessment of nutritional status and supplementation. 
Consultations with nutritionist to provide patient 
education regarding postgastrectomy diet; (2) 
Intravenous antibiotic prophylaxis; (3) Fluid and 
electrolyte correction; (4) Assessment of coagulation 
profile and correction of decreased prothrombin time by 
administration of vitamin K in patients with advanced 
jaundice; (5) Preoperative biliary drainage in jaundiced 
patients is indicated in patients with cholangitis 
and those with profound hyperbilirubinemia as this 
may impact coagulation status and wound healing. 
Preoperative stenting may be associated with increased 
postoperative infectious complications; (6) Standard 
treatment for dyspepsia and loss of appetite with 
a comprehensive management of pain; (7) Assessment 
of cardiac, renal, and pulmonary status; (8) Medical 
rehabilitations interventions usually, for patients 
experiencing pre or postoperative deconditioning, most 
commonly experienced postoperative complications or 
had preexisting conditions e.g. pain; (9) Assessment of 
the patient mental status and supportive psychotherapy 
especially for patient with adjustment disorders or 
depressions. 
Carcinoid tumors of the papilla Vater’s are very 
rarely found, but the true incidence might be much 
higher, and the tumors frequently have aggressive 
behavior. Carcinoid tumors of the papilla Vater’s 
should be included in the differential diagnosis of 
recurrent abdominal pain, cholangitis or pancreatitis 
of unknown cause. By doing a comprehensive geriatric 
assessment, with a careful modality selection, this case 
can have a good prognostic future.
PDE is the treatment of choice not only for 
ampullary carcinoma but also for adenoma with 
high grade dysplasia also for elderly persons in good 
somatical status;1 for frail unfit persons with distant 
metastases or miscellaneous contraindications for 
surgery remains endoscopic sphincterotomy and 
stenting a valid alternative of palliative treatment.
With good teamwork and interdisciplinary 
management with comprehensive geriatric assessment, 
the treatment or palliative care and quality of life can 
increase. 
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